The biosensors market size was exhibited at USD 30.25 billion in 2024 and is projected to hit around USD 69.67 billion by 2034, growing at a CAGR of 8.7% during the forecast period 2025 to 2034.
The U.S. biosensors market size is evaluated at USD 9.3 billion in 2024 and is projected to be worth around USD 21.4 billion by 2034, growing at a CAGR of 7.87% from 2025 to 2034.
North America held the largest share of more than 41.0% of the revenue in 2024 owing to the presence of key players and high incidence of targeted diseases in the region. Over the projected period, technological improvements, such as the introduction of miniaturized diagnostic equipment that provides increased market penetration of Electronic Medical Records (EMR), as well as precise & quick findings, are expected to fuel market expansion. Furthermore, the Clean Air Act, Clean Water Act, and National Environmental Policy Act all exist in the U.S. and are projected to create growth possibilities for the regional market.
Asia Pacific is expected to witness the fastest CAGR of 9.9% from 2025 to 2034. The presence of significant unmet medical requirements for target diseases, such as cancer, diabetes, and other infectious diseases, as well as continuously improving healthcare expenditure in the region and increasing patient awareness, drive the regional market growth. Increasing demand for home healthcare, PoC, and other healthcare businesses serving the adult population and government efforts to reduce hospital stays through the creation of outpatient care models are likely to drive market growth.
| Report Coverage | Details |
| Market Size in 2025 | USD 32.88 Billion |
| Market Size by 2034 | USD 69.67 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 8.7% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Technology, Application, End-user, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | Abbott Laboratories; Medtronic; Biosensors International Group; Pinnacle Technology, Inc.; Dupont. ; Sensirion AG; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Siemens Healthineers; Zimmer & Peacock AS; Metrohm AG; DexCom, Inc.; Universal Biosensors, Inc.; Johnson & Johnson Services, Inc.; Nix Biosensors; Cyrcadia Health; Lifescank |
Based on technology, the industry is categorized into piezoelectric, electrochemical, thermal, and optical. The electrochemical segment captured the largest market share of around 71.7% in 2024 and is expected to grow at the fastest CAGR of 8.7% from 2025 to 2034. This is due to its ubiquitous use in biochemical and biological processes for measurement and analysis. Low detection limits, wide linear response range, excellent stability, and repeatability are all advantages of electrochemical biosensors. Electrochemical detection has a number of advantages over piezoelectric, thermal, and optical detection, resulting in higher market penetration and consumption.
Robustness, compatibility with new microfabrication technologies, ease of operation, low cost, disposability, independence from sample turbidity, and low power needs are among a few benefits. The optical segment is expected to witness significant CAGR from 2025 to 2034. The need for optical biosensors in the analysis is predicted to increase throughout the forecast period owing to their broad analytical coverage. Receptor-cell interactions, fermentation monitoring, structural research, concentration, kinetic, and equilibrium analyses are all possible with optical biosensors. The market for optical biosensors is expected to grow as a result of these factors.
Based on applications, the industry is segmented into bioreactor, medical, agriculture, environment, food toxicity, and others. In 2024, the medical segment dominated the industry and accounted for around 66.8% of the total revenue share. Biosensors are used in the fields of cholesterol testing, blood glucose monitoring, drug discovery, pregnancy testing, blood gas analyzer, and infectious disorders in the medical segment. It is regarded as a vital instrument in the identification and monitoring of a wide range of medical diseases, including diabetes and cancer.The agriculture segment will register the fastest CAGR of 9.8% from 2025 to 2034.
In comparison to traditional techniques used to prevent the loss of livestock and crops due to natural threats and bioterrorism, biosensors allow rapid and specific identification of numerous funguses. Pesticides, heavy metals, and herbicides, as well as pesticides in the ground and soil water, are measured with this instrument. These are also utilized to predict the emergence of soil disease, which was previously impossible with conventional technology, and thus, provide dependable, improved methods for soil disease cleanup and prevention at an early stage. These factors boost the market’s expansion.
The end-user segment includes research laboratories, the food industry, home healthcare diagnostics and security POC testing, and bio-defense. Biosensors in point-of-care testing led the market in 2024 accounting for a revenue share of 48.0%. Key factors driving the segment growth include technological advancements that create innovative products, such as ultra-sensitive printable biosensors for PoC applications that help detect or monitor organic fluids like urine, saliva, blood, and sweat.
For instance, in August 2022, NanoDx, Inc., a developer of innovative medical diagnostic solutions, and SkyWater Technology announced the first commercially available protein-responsive nano biosensor. The food industry segment is anticipated to witness the fastest CAGR of 9.5% from 2025 to 2034. Its capacity to tackle many issues in the food processing sector, such as minimizing expenses incurred during hygiene analysis by precise tests and offering speedy findings, are key elements contributing to its rapid growth. There are some potential application areas of biosensors in the food industry including fast analysis of food to keep the product freshness and raw material inspections on a regular basis.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the biosensors market
By Technology
By Application
By End-user
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Biosensors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Biosensors Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2024 & 2034
4.2. Segment Dashboard
4.3. Global Biosensors Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
4.4.1. Thermal
4.4.1.1. Market estimates and forecasts 2021 to 2034 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market estimates and forecasts 2021 to 2034 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market estimates and forecasts 2021 to 2034 (USD Million)
4.4.4. Optical
4.4.4.1. Market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 5. Biosensors Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2024 & 2034
5.2. Segment Dashboard
5.3. Global Biosensors Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
5.4.1. Medical
5.4.1.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.2. Cholesterol
5.4.2.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.3. Blood Glucose
5.4.3.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.4. Blood Gas Analyzer
5.4.4.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.5. Pregnancy Testing
5.4.5.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.6. Drug Discovery
5.4.6.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.7. Infectious Disease
5.4.7.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.8. Food Toxicity
5.4.8.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.9. Bioreactor
5.4.9.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.10. Agriculture
5.4.10.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.11. Environment
5.4.11.1. Market estimates and forecasts 2021 to 2034 (USD Million)
5.4.12. Others
5.4.12.1. Market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 6. Biosensors Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2024 & 2034
6.2. Segment Dashboard
6.3. Global Biosensors Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
6.4.1. Home Healthcare Diagnostics
6.4.1.1. Market estimates and forecasts 2021 to 2034 (USD million)
6.4.2. POC Testing
6.4.2.1. Market estimates and forecasts 2021 to 2034 (USD million)
6.4.3. Food Industry
6.4.3.1. Market estimates and forecasts 2021 to 2034 (USD million)
6.4.4. Research Laboratories
6.4.4.1. Market estimates and forecasts 2021 to 2034 (USD million)
6.4.5. Security and Bio-Defense
6.4.5.1. Market estimates and forecasts 2021 to 2034 (USD million)
Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2034
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2034:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2021 to 2034 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2021 to 2034 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2021 to 2034 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2021 to 2034 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2021 to 2034 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2021 to 2034 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2021 to 2034 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2021 to 2034 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2021 to 2034 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2021 to 2034 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2021 to 2034 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2021 to 2034 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2021 to 2034 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2021 to 2034 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2021 to 2034 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2021 to 2034 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2021 to 2034 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2021 to 2034 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2021 to 2034 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2021 to 2034 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2034 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2021 to 2034 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.4 Company Profiles
8.4.1 Abbott Laboratories
8.4.1.1 Company overview
8.4.1.2 Financial Performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 MEDTRONIC
8.4.2.1 Company overview
8.4.2.2 Financial Performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Pinnacle Technology, Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Product benchmarking
8.4.4 BIOSENSORS INTERNATIONAL GROUP, LTD.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Dupont
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Sensirion AG
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 Thermo Fisher Scientific, Inc.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Siemens Healthineers
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Zimmer & Peacock AS
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Metrohm AG
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 DexCom, Inc.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
8.4.12 Universal Biosensors, Inc.
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 Johnson & Johnson Services, Inc.
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 Nix Biosensors
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Cyrcadia Health
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
8.4.16 Lifescan
8.4.16.1 Company overview
8.4.16.2 Financial performance
8.4.16.3 Product benchmarking
8.4.16.4 Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers